Browsing by Subject "Dosis"
Now showing items 1-1 of 1
-
Controversies in cerebrovascular disease: high or low doses of recombinant tissue plasminogen activator to treat acute stroke? A literature review
(Sociedad Española de Neurología, 2022-03-01)Acceso abiertoIntroduction: The use of low doses of recombinant tissue plasminogen activator (rt-PA) was initially proposed in Asian countries in response to racial peculiarities related to the functionality of fibrinogen and coagulation ...